195 related articles for article (PubMed ID: 10963743)
1. Regulation of 5-HT(2A) receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserin.
Anji A; Kumari M; Sullivan Hanley NR; Bryan GL; Hensler JG
Neuropharmacology; 2000 Aug; 39(11):1996-2005. PubMed ID: 10963743
[TBL] [Abstract][Full Text] [Related]
2. Selective heterologous regulation of 5-HT1A receptor-stimulated 35S GTPgammaS binding in the anterior cingulate cortex as a result of 5-HT2 receptor activation.
Valdez M; Burke TF; Hensler JG
Brain Res; 2002 Dec; 957(1):174-82. PubMed ID: 12443993
[TBL] [Abstract][Full Text] [Related]
3. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
[TBL] [Abstract][Full Text] [Related]
4. 5-HT(2A/2C) receptor antagonists in the paraventricular nucleus attenuate the action of DOI on NPY-stimulated eating.
Currie PJ; Saxena N; Tu AY
Neuroreport; 1999 Sep; 10(14):3033-6. PubMed ID: 10549818
[TBL] [Abstract][Full Text] [Related]
5. An immunocapture/scintillation proximity analysis of G alpha q/11 activation by native serotonin (5-HT)2A receptors in rat cortex: blockade by clozapine and mirtazapine.
Mannoury La Cour C; Chaput C; Touzard M; Millan MJ
Synapse; 2009 Feb; 63(2):95-105. PubMed ID: 19016481
[TBL] [Abstract][Full Text] [Related]
6. Sustained treatment with a 5-HT(2A) receptor agonist causes functional desensitization and reductions in agonist-labeled 5-HT(2A) receptors despite increases in receptor protein levels in rats.
Shi J; Landry M; Carrasco GA; Battaglia G; Muma NA
Neuropharmacology; 2008 Oct; 55(5):687-92. PubMed ID: 18588902
[TBL] [Abstract][Full Text] [Related]
7. Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion.
Basura GJ; Walker PD
Brain Res Mol Brain Res; 2001 Aug; 92(1-2):66-77. PubMed ID: 11483243
[TBL] [Abstract][Full Text] [Related]
8. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
Ferry RC; Unsworth CD; Molinoff PB
Mol Pharmacol; 1993 May; 43(5):726-33. PubMed ID: 8388988
[TBL] [Abstract][Full Text] [Related]
9. The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats.
Scruggs JL; Schmidt D; Deutch AY
Neurosci Lett; 2003 Aug; 346(3):137-40. PubMed ID: 12853103
[TBL] [Abstract][Full Text] [Related]
10. Effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on plasma glucose and glucagon levels of rats.
Sugimoto Y; Yamada J
Biol Pharm Bull; 2000 Dec; 23(12):1521-3. PubMed ID: 11145190
[TBL] [Abstract][Full Text] [Related]
11. DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons.
Scruggs JL; Patel S; Bubser M; Deutch AY
J Neurosci; 2000 Dec; 20(23):8846-52. PubMed ID: 11102493
[TBL] [Abstract][Full Text] [Related]
12. Agonist induced-phosphorylation of Galpha11 protein reduces coupling to 5-HT2A receptors.
Shi J; Damjanoska KJ; Singh RK; Carrasco GA; Garcia F; Grippo AJ; Landry M; Sullivan NR; Battaglia G; Muma NA
J Pharmacol Exp Ther; 2007 Oct; 323(1):248-56. PubMed ID: 17646429
[TBL] [Abstract][Full Text] [Related]
13. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
Willins DL; Meltzer HY
J Pharmacol Exp Ther; 1997 Aug; 282(2):699-706. PubMed ID: 9262333
[TBL] [Abstract][Full Text] [Related]
14. Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus.
Damjanoska KJ; Heidenreich BA; Kindel GH; D'Souza DN; Zhang Y; Garcia F; Battaglia G; Wolf WA; Van de Kar LD; Muma NA
J Pharmacol Exp Ther; 2004 Jun; 309(3):1043-50. PubMed ID: 14976228
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of rat peripheral 5-HT(2A) and 5-HT(2B) receptor systems: influence of drug treatment.
Enguix MJ; Sánchez L; Villazón M; Brea J; Tristán H; Caruncho HJ; Cadavid MI; Loza MI
Naunyn Schmiedebergs Arch Pharmacol; 2003 Aug; 368(2):79-90. PubMed ID: 12861437
[TBL] [Abstract][Full Text] [Related]
16. Role of 5-HT(2) receptors in the tryptamine-induced 5-HT syndrome in rats.
Van Oekelen D; Megens A; Meert T; Luyten WH; Leysen JE
Behav Pharmacol; 2002 Jul; 13(4):313-8. PubMed ID: 12218512
[TBL] [Abstract][Full Text] [Related]
17. The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortex.
Kettle CJ; Cheetham SC; Martin KF; Prow MR; Heal DJ
Neuropharmacology; 1999 Sep; 38(9):1421-30. PubMed ID: 10471096
[TBL] [Abstract][Full Text] [Related]
18. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice.
Dougherty JP; Aloyo VJ
Psychopharmacology (Berl); 2011 Jun; 215(3):581-93. PubMed ID: 21340474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
